Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G1OZ
|
|||
| Former ID |
DAP000898
|
|||
| Drug Name |
Mephentermine
|
|||
| Synonyms |
Mefenterdrin; Mefentermin; Mefentermina; Mephenterdrine; Mephenterdrinum; Mephenterminum; Mephetedrine; Mephine; Vialin; Wyamine; Wyfentermina; Mefentermina [INN-Spanish]; Mephentermine (INN); Mephentermine [INN:BAN]; Mephenterminum [INN-Latin]; N-Methylphentermine; WY-585; Mephentermine Sulfate (2:1); N,alpha,alpha-Trimethylbenzeneethanamine; N,alpha,alpha-Trimethylphenethylamine; Omega-Phenyl-tert-butyl-methylamine; N-Methyl-omega-phenyl-t-butylamine; N-Methyl-omega-phenyl-tert-butylamine; N,2-dimethyl-1-phenylpropan-2-amine; 2-Methyl-2-methylamino-1-phenylpropane; 2-Methylamino-2-methyl-1-phenylpropane
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | High blood pressure [ICD-11: BA00; ICD-10: I10] | Approved | [1] | |
| Therapeutic Class |
Vasoconstrictor Agents
|
|||
| Company |
Baxter Healthcare Corp Anesthesia Critical Care
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H17N
|
|||
| Canonical SMILES |
CC(C)(CC1=CC=CC=C1)NC
|
|||
| InChI |
1S/C11H17N/c1-11(2,12-3)9-10-7-5-4-6-8-10/h4-8,12H,9H2,1-3H3
|
|||
| InChIKey |
RXQCGGRTAILOIN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 100-92-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10091, 5152744, 7979903, 8152323, 10502228, 11112475, 11335404, 11360643, 11364505, 11367067, 11369629, 11372239, 11373874, 11377791, 11461615, 11466754, 11467874, 11484344, 11486327, 11488290, 11491035, 11492003, 11495425, 14772475, 29222800, 46505918, 47291289, 47810934, 47959942, 48185153, 48334678, 48334679, 48334680, 48416215, 49698940, 50004733, 50100459, 50100460, 57321934, 74493046, 96024870, 104304202, 118263315, 123085522, 124577122, 125822957, 126671824, 131342029, 132564025, 134222260
|
|||
| ChEBI ID |
CHEBI:6755
|
|||
| SuperDrug ATC ID |
C01CA11
|
|||
| SuperDrug CAS ID |
cas=000100925
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Present state of alpha- and beta-adrenergic drugs I. The adrenergic receptor. Am Heart J. 1976 Nov;92(5):661-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.